共 468 条
[1]
Loeb DM(2008)Pediatric soft tissue sarcomas Surg Clin North Am 88 615-627
[2]
Thornton K(2010)Selecting multimodal therapy for rhabdomyosarcoma Expert Rev Anticancer Ther 10 1285-1301
[3]
Shokek O(2010)Outcomes for children and adolescents with cancer: challenges for the twenty-first century J Clin Oncol 28 2625-2634
[4]
Sultan I(1999)Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group J Clin Oncol 17 3487-3493
[5]
Ferrari A(2005)Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma Cancer 104 183-190
[6]
Smith MA(2008)Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups J Clin Oncol 26 2384-2389
[7]
Seibel NL(1993)Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis Science 259 1450-1453
[8]
Altekruse SF(2008)NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma Cancer Cell 14 369-381
[9]
Ries LA(2009)The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation J Clin Invest 119 2366-2378
[10]
Melbert DL(2012)Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo Cell Death Differ 19 871-881